Psychiatry Research
Volume 157, Issue 1 , Pages 47-52 , 15 January 2008

Predictors of medication competence in schizophrenia patients

  • R. Walter Heinrichs

      Affiliations

    • Department of Psychology, York University, 4700 Keele Street, Toronto, Ontario, Canada M3J 1P3
    • Corresponding Author InformationCorresponding author. Tel.: +1 416 736 2100x66205; fax: +1 416 736 5814.
    • ,
  • Joel O. Goldberg

      Affiliations

    • Hamilton Program for Schizophrenia, Hamilton, Ontario, Canada
    • ,
  • Ashley A. Miles

      Affiliations

    • Department of Psychology, York University, 4700 Keele Street, Toronto, Ontario, Canada M3J 1P3
    • ,
  • Stephanie McDermid Vaz

      Affiliations

    • Cleghorn Early Intervention in Psychosis Program, St. Joseph's Healthcare, Hamilton, Ontario, Canada

Received 4 August 2006 ,Revised 27 December 2006 ,Accepted 15 February 2007.

References 

  1. Albert SM, Weber C, Todak G, Polanco C, Clouse R, McElhiney M, et al. An observed performance test of medication management ability in HIV: relation to neuropsychological status and medication adherence outcomes. AIDS and Behavior. 1999;3:121–128
  2. Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. Journal of Clinical Psychiatry. 2006;67:453–460
  3. Chomsky N. Aspects of the Theory of Syntax. The Hague, NL: Mouton; 1965;
  4. Delis DD, Kramer J, Kaplan E, Ober BA. California Verbal Learning Test–Second Edition. San Antonio, TX: The Psychological Corporation; 2000;
  5. Dolder CR, Lacro JP, Leckband S, Jeste DV. Interventions to improve antipsychotic medication adherence: review of recent literature. Journal of Clinical Psychopharmacology. 2003;23:389–399
  6. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorder–Patient Edition (SCID-I/P). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 2002;
  7. Griffin SL, Rivera Mindt M, Rankin EJ, Richie AJ, Scott JG. Estimating premorbid intelligence: comparison of traditional and contemporary methods across the intelligence continuum. Archives of Clinical Neuropsychology. 2002;17:497–507
  8. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminant validity. Psychological Medicine. 1983;13:177–183
  9. Jaeger J, Berns SM, Czobor P. The multidimensional scale of independent functioning: a new instrument for measuring functional disability in psychiatric populations. Schizophrenia Bulletin. 2003;29:153–168
  10. Jeste SD, Patterson TE, Palmer BW, Dolder CR, Goldman S, Jeste DV. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophrenia Research. 2003;63:49–58
  11. Le Corre M, Van de Walle G, Brannon EM, Carey S. Re-visiting the competence/performance debate in the acquisition of the counting principles. Cognitive Psychology. 2006;52:130–169
  12. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophrenia Research. 2004;72:29–39
  13. Opler LA, Kay SR, Lindenmayer JP, Fiszbein A. Structured Clinical Interview: The Positive and Negative Syndrome Scale (SCI–PANSS). North Tonawanda, NY: Multi-Health Systems Inc; 1999;
  14. Patterson TL, Lacro J, McKibbin CL, Moscona S, Hughs T, Jeste DV. Medication Management Ability Assessment: results from a performance-based measure in older outpatients with schizophrenia. Journal of Clinical Psychopharmacology. 2002;22:11–19
  15. Penades R, Catalan R, Salamero M, Boget T, Puig O, Guarch J, et al. Cognitive remediation therapy for outpatients with chronic schizophrenia: a controlled and randomized study. Schizophrenia Research. 2006;87:323–331
  16. Pratt SI, Mueser KT, Driscoll M, Wolfe R, Bartels SJ. Medication nonadherence in older people with serious mental illness: prevalence and correlates. Psychiatric Rehabilitation Journal. 2006;29:299–310
  17. Velligan DI, Lam YW, Glahn DC, Barrett JA, Maples NJ, Ereshevsky L, et al. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophrenia Bulletin. 2006;32:724–742
  18. Voruganti LN, Awad AG. Personal Evaluation of Transitions in Treatment (PETiT): a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophrenia Research. 2002;56:37–46
  19. Wechsler D. Wechsler Adult Intelligence Scale–Third Edition. San Antonio, TX: The Psychological Corporation; 1997;
  20. Wilkinson GS. The Wide Range Achievement Test Administration Manual. Wilmington, DE: Wide Range; 1993;
  21. Yamada K, Watanabe K, Nemoto N, Fujita H, Chikaraishi C, Yamauchi K, et al. Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study. Psychiatry Research. 2006;141:61–69

PII: S0165-1781(07)00080-7

doi: 10.1016/j.psychres.2007.02.015

Psychiatry Research
Volume 157, Issue 1 , Pages 47-52 , 15 January 2008

Article Tools